Key result
A Pro BNP level greater than 2500 ng/l was significantly associated with increased one-year mortality (OR 19) in outpatients with heart failure.
Why the study?
The study investigated the difference in association between cardiovascular prognostic markers and one-year mortality in outpatients with heart failure.
Does the assessment of cardiovascular prognostic markers predict one-year mortality in an outpatient population with heart failure?
Cross-Sectional (n=76)
No
Does the assessment of cardiovascular prognostic markers predict one-year mortality in an outpatient population with heart failure?
May aid mortality risk assessment in HF outpatients; hypothesis-generating and requires prospective validation.
Objective: This cross-sectional study investigated the difference in association between cardiovascular prognostic markers and one-year mortality in a population with heart failure and followed outpatient.
No takes yet. Share an insight, caveat, or question.
Jimmy Duc (2020) conducted a cross-sectional in Heart failure (n=76). Pro BNP > 2500 ng/l vs. Pro BNP ≤ 2500 ng/l was evaluated on One-year mortality (OR 19, 95% CI 4.13-86, p=<0.05). A Pro BNP level greater than 2500 ng/l was significantly associated with increased one-year mortality (OR 19) in outpatients with heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: